SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Technology Stocks : e.Digital Corporation(EDIG) - Embedded Digital Technology -- Ignore unavailable to you. Want to Upgrade?


To: Savant who wrote (4337)5/18/1999 1:12:00 PM
From: R. Bond  Read Replies (2) | Respond to of 18366
 
FYI:

(BSNS WIRE) Music Web Site Wages Challenge to MP3.com; Receives Support
Music Web Site Wages Challenge to MP3.com; Receives Support From Major Artists


Business/Entertainment Editors and High-Tech Writers

IRVINE, Calif.--(BUSINESS WIRE)--May 18, 1999--In an aggressive
move, StreamlineMusic.com Tuesday launched a new business model that
will, by all indications, offer the industry giant MP3.com a sure-fire
run for its money.
Murphy Karges, from the platinum-selling band Sugar Ray,
commented, "StreamlineMusic.com will be a great collecting place for
the music industry. This is the way music technology is going."
StreamlineMusic.com markets and distributes music, giving 100
percent of the profit from sales to the artist or record label. The
company will generate its own revenue via advertising sales and
sponsorship.
"Sites like MP3.com and others that claim to be doing something
'revolutionary' take 50 percent or more of a sale for really doing
nothing more than providing a little server space," said Ruben Lozano,
president of StreamlineMusic.com.
"At StreamlineMusic,.com artists and labels retain 100 percent of
what is rightfully theirs. Now that's revolutionary."
"StreamlineMusic.com is a great way for both new and veteran
bands to put the power of the Internet behind their music," said John
Maurer of the legendary punk band, Social Distortion.
"StreamlineMusic.com is the most exciting thing to happen to the
music industry since the CD," said Maurer, who plans to distribute his
own solo work through this site.
Jake Bergman of the unsigned Southern California alternative
band, the GoForthGetters, sees it this way, "The Internet is the
perfect medium for self-promotion and StreamlineMusic.com has given us
the ability to self-promote on the Web for free, and their reach is
worldwide."
Tony Terusa of one of the hottest and top-selling Christian bands
in the country, The OC Supertones, added, "We as a band cannot wait
to see the impact that Streamlinemusic.com will have in effectively
utilizing the Internet as a tool to distribute music. Their plan is
efficient and ethical, and it looks out for everyone. We are
thrilled."
The concept, birthed by Lozano, was hatched as a result of his
love of music and searching for a better way of distributing it to the
market that benefits all parties involved.
Artists and record companies have complete control over the
pricing of any products they sell through StreamlineMusic.com and the
format in which it is distributed. Until now, record labels have been
reluctant, at best, to dive headlong into downloadable music sales for
fear of piracy. However, new formats such as Liquid Audio, AT&T Lab's
a2b music, and Microsoft's MS Audio 4.0 now offer them secure means of
distribution.
Products can be sold in the form of downloadable files, or even a
physical CD. The company will warehouse and ship CDs as part of its
service. However, a large portion of the music on StreamlineMusic.com
will be free to all music fans.
The company is inviting artists, labels, and music fans to
register at its Web site, streamlinemusic.com. Artists and labels can
sign up and receive a free Web page to promote their music, free music
download hosting and streaming, and product fulfillment support. The
company expects to be in full swing by July 4, 1999.

--30--RMS/np* JS/np

CONTACT: StreamlineMusic.com, Irvine
Troy Meier, 877/891-7001
E-mail: ruben@streamlinemusic.com

KEYWORD: CALIFORNIA
INDUSTRY KEYWORD: COMPUTERS/ELECTRONICS COMED ENTERTAINMENT
INTERACTIVE/MULTIMEDIA/INTERNET

Today's News On The Net - Business Wire's full file on the Internet
with Hyperlinks to your home page.
URL: businesswire.com




*** end of story ***



To: Savant who wrote (4337)5/20/1999 1:55:00 PM
From: R. Bond  Read Replies (1) | Respond to of 18366
 
**OT**

Savant,

Saw this new item and thought it may be just the thing to help Jason Olim along:

(PR NEWSWIRE) First Medication for the Treatment of Social Anxiety Disorde
First Medication for the Treatment of Social Anxiety Disorder Approved by the
FDA

SmithKline Beecham's Paxil(R) to Treat Highly Debilitating Condition

PHILADELPHIA, May 11 /PRNewswire/ -- SmithKline Beecham (NYSE: SBH) today
announced that the U.S. Food and Drug Administration (FDA) approved Paxil(R)
(paroxetine HCl) for the treatment of social anxiety disorder, making it the
first and only medication approved for this disorder in the United States.
Affecting over 10 million Americans, social anxiety disorder, also known
as social phobia, is the most common type of anxiety disorder and the third
most common psychiatric disorder after depression and alcoholism. Social
anxiety disorder is also considered one of the most neglected anxiety
disorders, with only five percent of patients receiving some form of
treatment.
People with social anxiety disorder have an intense fear of being
scrutinized by other people in social or performance situations and of
negative evaluation. They literally become "sick with fear" and are afraid of
acting in a way that will be embarrassing or humiliating, causing them to
avoid such situations in the future or endure these "everyday" situations with
dread. These situations may include speaking in public, initiating or
maintaining a conversation with strangers or people in authority,
participating in meetings or classes, attending parties or dating.
"The FDA approval of Paxil for the treatment of social anxiety disorder
provides a much-needed addition to the physician's armamentarium against
mental illness," said Rodrigo Munoz, M.D., president of the American
Psychiatric Association and clinical professor of psychiatry, University of
California at San Diego. "The FDA's action has given psychiatrists and other
physicians an approved option from which to develop effective treatment plans
for this debilitating disorder -- usually combining medication and some form
of psychotherapy."


*** end of story ***